The agreement provides Aesculap with the right to sell in the US and includes minimum purchase requirements and the payment of a royalty on sales of disposables.
Michael McManus, Jr, president and CEO of Misonix, said: “We have been working with Aesculap for many years in the distribution of our Sonastar ultrasonic aspirator for neurosurgery and know them to be true professionals that understand the market, particularly for technologically enhanced medical devices. The opportunity to sell the Sonastar and the BoneScalpel together will create additional leverage in the market that will be a benefit to both companies.”